Endonovo Therapeutics Inc (ENDV): Hard to understand the plan of this comp...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Re: None

Tuesday, 09/27/2022 5:40:02 PM

Tuesday, September 27, 2022 5:40:02 PM

Hard to understand the plan of this company, but if they keep up then this will be a good investment for the strong hands...

Keep Last Read

Next 10 Prev Next

Form SEC STAFF ACTION - SEC Staff Action: ORDER • Edgar (US Regulatory) • 09/19/2024 07:00:01 PM
Form 15-12G - Securities registration termination [Section 12(g)] • Edgar (US Regulatory) • 02/02/2024 10:23:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 01/03/2024 10:30:14 PM
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend] • Edgar (US Regulatory) • 12/29/2023 08:20:36 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/04/2023 02:08:41 PM
Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 05:21:48 PM
Form 8-K - Current report • Edgar (US Regulatory) • 10/12/2023 10:03:32 AM

InvestorsHub NewsWire

Only $200 per official company press release!